P1.15-05. Nintedanib in Combination with Nivolumab in Pretreated Patients with Advanced Adenocarcinoma of the Lung (AIO-TRK-0117 Phase IB/II Trial)
Back to course
Pdf Summary
Asset Subtitle
Martin Reck, Germany
Meta Tag
Speaker Martin Reck, Germany
Topic Metastatic Non-small Cell Lung Cancer – Immunotherapy
NintNivo trial
therapeutic potential
non-squamous non-small cell lung cancer
advanced NSCLC
immune checkpoint inhibitor
anti-angiogenisis agent
progression-free survival
objective response rate
Powered By